Sun Pharma Q3 beats estimates, net profit rises 19%; declares ₹10.50 interim dividend
EBITDA surged 25% to ₹4,192.2 crore and the EBITDA margin stood at 30.7% in the reporting quarter compared to 27.1% in the year-ago period. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,743.10, down by ₹2.15, or 0.12%, on the BSE.
EBITDA surged 25% to ₹4,192.2 crore and the EBITDA margin stood at 30.7% in the reporting quarter compared to 27.1% in the year-ago period. Shares of Sun Pharmaceutical Industries Ltd ended at ₹1,743.10, down by ₹2.15, or 0.12%, on the BSE.
What's Your Reaction?
FEDA-HQ
The Federation of Economic Development Association of India (F.E.D.A) holds the distinction of being India's most venerable umbrella organization. F.E.D.A focused on promoting economic growth in India. Economic development professionals throughout the state, along with individuals and companies in related economic development fields, work together with the F.E.D.A Members and Board of Federation to help positively influence country legislation and industrial growth. With cutting edge policy research and advisory to National and State governments on trade issues. F.E.D.A is one of the leading non-profit organizations with established credentials for enhancing economic development.
